Nicorandil potentiates sodium butyrate induced preconditioning of neurons and enhances their survival upon subsequent treatment with H2O2.

BACKGROUND: Extensive loss of donor neural stem cell (NSCs) due to ischemic stress and low rate of differentiation at the site of cell graft are two of the major issues that hamper optimal outcome in NSCs transplantation studies. Given that histone deacetylases (HDACs) modulate various cellular processes by deacetylating histones and non-histone proteins, we hypothesized that combined treatment with small molecules, sodium butyrate (NaB; a known HDAC inhibitor) and nicorandil, will enhance the rate neuronal differentiation of NSCs besides their preconditioning to resist oxidative stress.
METHODS: NSCs derived from 14-day old Sprague Dawley rat ganglion eminence were characterized for tri-lineage differentiation. Treatment with 1 mM NaB significantly changed their culture characteristics while continuous treatment for 10 days enhanced their neural differentiation. NaB treatment also preconditioned the cells for their resistance to oxidative stress.
RESULTS: The highest rate of neural differentiation and preconditioning effect was achieved when the NSCs were treated concomitantly with NaB and nicorandil. Cell proliferation assay showed that concomitant treatment with NaB and nicorandil retarded their rate of proliferation.
CONCLUSION: These data conclude that preconditioning of NSCs with NaB and nicorandil effectively enhances their differentiation capacity besides preconditioning the cells to support their survival under ischemic conditions.

Background

Neural stem cells (NSCs) isolated from the adult and fetal nervous tissue, have been extensively studied for tri-lineage differentiation potential including neurons, oligodendrocytes and astrocytes in vitro as well as post-engraftment in experimental animal models [1]. One of the major problems during the experimental animal studies is the extensive apoptosis of donor NSCs post-engraftment due to the ischemic stress. It might also be the consequence of nutrient deprivation and oxidative load caused by the free radicals [2]. Regardless of the underlying cause, the altered oxidative load remains a significant determinant of the cell fate and function. The biochemical cues and inflammatory response emanating from the ischemic tissue activate redox-sensitive signaling pathways in the cells thus lowering the oxidative load to favor cell proliferation [3]. These molecular changes activate PI3K/Akt signaling via oxidative inactivation of PTEN thus promoting cell proliferation. On the contrary, as the concentration of reactive oxygen species (ROS) increases in the cells, the intracellular environment becomes more conducive for differentiation instead of supporting cell proliferation. This molecular mechanism holds true for both neural progenitor cells and glial precursor cells [4].

Histone deacetylases (HDACs) are modulators of gene expression profile and thus influence the various intracellular processes encompassing from survival to differentiation by deacetylating both histone and non-histone proteins [5]. Hence, treatment of NSCs with small molecule HDAC inhibitors (HDACi) exerts neuroprotective effects and stimulates neurogenesis [6, 7]. A series of small molecules including valproic acid (VPA), sub-eroylanilidec hydroxamic acids (SAHA), benzamide (MS-275), M344 and the short-chain fatty acid sodium butyrate (NaB) have been studied to modulate neural differentiation of stem cells [5, 8]. HDACi treatment of NSCs under pro-proliferation culture conditions leads to long-term changes in the cell fate in vitro by different mechanisms including inhibition of DNA synthesis [9] and by G1-phase arrest of the cell cycle [5]. HDACi also promote transcriptional changes in NSCs by increasing Cdk inhibitor genes p21 and p27 transcription and elevated H3K9 acetylation at proximal promoter regions of p21 and p27 [5].

Apurinic pyrimidinic endonuclease-1/Redox effector factor-1 (APE-1/Ref-1) is crucial for cellular response to oxidative stress [10]. This is achieved by N-terminus lysine reaction with the nucleic acids and nucleophosmin besides base excision repair through C-terminus initiating enzymatic activity. The anti-apoptotic function of APE1 under oxidative stress has been confirmed via activation of nuclear factor-kappa B (NF-kB) signaling [11, 12]. Nicorandil is a stimulator of the APE1 pathway in the neurons subjected to oxidative stress [13, 14]. The present study was designed to determine the combined protective effect of NaB and nicorandil on NSCs under oxidative stress. We hypothesized that serial treatment of NSCs with NaB (HDACi) followed by nicorandil (as the APE1 stimulator) would promote neuronal differentiation of NSCs that would be preconditioned to resist oxidative stress.

Methods

The present study conformed to the Guideline for the Care and Use of Laboratory Animals and all the experimental animal procedures were performed strictly in accordance with protocol approved by Ethical Committee of Shiraz University of Medical Sciences, Iran. All surgical manipulations were carried out under general anesthesia. The results shown in the manuscript are replicate of five experiments.”

NSCs isolation and culture

NSCs were obtained from 14-day old Sprague Dawley rat ganglion eminence as described earlier (Additional file 1). One week after isolation, sphere-like colonies of neurospheres were observed that were trypsinized as single cells and passaged into new culture flasks at 50000 cells/ml concentration (Additional file 1).

Characterization of NSCs

NSCs were characterized for tri-lineage differentiation into neurons, astrocytes and oligodendrocytes as described earlier (Additional file 1).

Preconditioning with histone deacetylase inhibitor

For the differentiation NSCs using HDACi alone, the cells were treated with freshly prepared 1 mM NaB in distilled water (Cat# B5887, Sigma Aldrich, St. Louis, USA). NaB treatment was performed at 2 h after NSCs passage as single cell culture. Neural differentiation of NSCs was assessed by flow cytometry and immunocytochemistry on day-7 after NaB treatment.

For flow cytometry, the cells were fixed with 4% paraformaldehyde for 20 min at 4 °C. Subsequently, the cells were incubated with MAP-2 specific primary antibody (1:1000, cat # ab5392, Abcam, Cambridge, UK) at room temperature. After one hour, the cells were washed with phosphate buffer saline (PBS) and the primary antigen-antibody reaction was detected by incubating the cells for 1 h at room temperature with fluorescently conjugated secondary antibody diluted in 5% goat serum. The MAP-2 positive cells were analyzed by flow cytometry (BD Bioscience, San Jose, USA). For microscopic analysis of MAP-2 positive cells, the cells were stained with 4′,6-diamidino-2-phenylindole (DAPI; 1:1000; Millipore S7113, Billerica, USA) and observed using fluorescence microscope (Olympus BX53; Tokyo, Japan). The MAP-2 positive neurons were counted in various microscopic fields and compared with the untreated control group.

Cell cluster and neurosphere count

The NSCs derived cell clusters and neurospheres were counted as described earlier [5]. One week after HDACi treatment, 10 randomly selected microscopic fields were counted using an inverted microscope (Olympus; Tokyo, Japan). The inclusion criteria was set as small cell cluster an aggregation of cell count > 4 cells but cell aggregation diameter of < 50 μm. For neurospheres, the diameter was set as more than 50 μm. The number of small cell clusters and neurospheres were compared with the control group [5].

Cell proliferation assay

5-Bromo-2′-deoxyuridine (BrdU) immunocytochemistry was performed to assess NSCs proliferation after NaB treatment. In brief, after NaB treatment, 1 × 105 cells in 96-well plates were incubated with 25 μM BrdU (Cat #B5002; Sigma-Aldrich; St.Louis, USA). After 16 h, the cells were washed and fixed with 4% paraformaldehyde for 20 min at 4 °C and later treated with 1 N HCl for 15 min at 37 °C. Subsequently, the cells were incubated with anti-BrdU specific primary antibody (Cat# B8434; 1:1000; Sigma-Aldrich; St. Louis, USA) in 0.1% triton and 2.5% BSA in PBS. The cells were kept at room temperature for 2 h followed by washing ×3 with PBS. The primary antigen-antibody reaction was detected with the Alexa flour-488 conjugated secondary antibody. The cells were incubated with the secondary antibody at 37 °C for 1 h, washed and observed using fluorescence microscope (Olympus BX53; Tokyo, Japan). Cell proliferation was measured by BrdU+/total number of cells in NaB treated group.

The data was analyzed by unpaired t-test using Prism 8.00 software.

Treatment with nicorandil

To determine the activation of the APE1 pathway, 12.5 μM nicorandil was added to the cells as described earlier [14].

Induction of apoptosis using H2O2

For induction of apoptosis, 500 μM H2O2 was added to the culture media for one hour at one hour after nicorandil treatment [15].

MTT assay

The viability of the preconditioned and control cells were assessed by MTT assay at 24 h after their exposure to H2O2. Briefly, NSCs culture media in different treatment groups was supplemented with 10 μl of 5 mg/ml 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) (Cat# M2128; Sigma-Aldrich; St. Louis, USA). The cells were then incubated at 37 °C for 4 h. At the end of the incubation period, the medium was removed, treated with acidic isopropanol (0.1 N HCl in isopropanol) and the samples were read using spectrophotometer at wavelength 570 nm [16]. The survival of the cells in control group (which was exposed to H2O2 without small molecule treatment) was considered as 100% and the other treatment groups were compared with the control. In accordance with the calculations, group survival of more than 100% represents the treatment as protective against H2O2 stress.

Annexin-V staining and flow cytometry

The resistance of the HDACi induced neurons to H2O2 treatment was assessed by flow cytometry using Annexin-V Apoptosis detection kit in combination with propidium iodide (PI) according to manufacturer’s instructions (Cat# 14085; Abcam; Cambridge, UK). Briefly, 5 × 105 cells with or without HDACi treatment were incubated with Annexin V-FITC/PI for 1 h at room temperature. After washing ×3 with PBS, the cells were harvested using Trypsin-EDTA. After washing ×2 with PBS, the cells were analyzed by flow cytometry (BD Bioscience, San Jose, USA) in FITC channel (488). The cells were stained with PI to discriminate the necrotic cells from the apoptotic cells and measured by flow cytometry. The apoptotic cells were defined as the ones staining positive for Annexin-V.

Colorimetric analysis and immunocytochemistry for caspase-3

The activity of caspase-3 was measured using caspase-3 Assay kit (Cat# ab39401; Abcam, Cambridge, USA) according to the manufacturer’s instructions. Immunocytochemistry for caspase 3 was performed with anti-caspase-3 antibody (Cat# MAB10753; Sigma Aldrich; St. Louis, USA).

Statistical analysis

Data were presented as mean ± STD. For quantitative analysis, data was analyzed with unpaired t-test and one-way ANOVA with post-hoc analysis using SPSS 16.00. A value of p˂0.05 was considered as statistically significant.

Results

NSCs culture and characterization

The isolated NSCs were cultured in NeuroCult NS-A media (Cat# 05750; Stem Cell Technology, Vancouver; Canada) and maintained at 37 °C and 5% CO2. After 5 days in the culture, NSCs started to form spherical cell aggregates or the neurospheres (Fig. 1a). The spherical cell aggregates were clearly distinguishable from the extraneous particulate material in the culture based on their morphology at higher magnification. Fluorescence immunocytochemistry with specific primary antibodies revealed their positivity for both Nestin (Fig. 1b-d) and CD133 expression (Fig. 1e-g). The neurospheres were dissociated into single cells and cultured in differentiating media for tri-lineage differentiation assay. Fluorescence immunocytochemistry showed their successful differentiation into neurons; oligodendrocytes and astrocytes as was evident from positivity for CNPase (for oligodendrocytes) and GFAP (for astrocytes) (Fig. 1h-j and k-m).

Fig. 1

Neural stem cell culture and characterization. a Phase contrast image of neural stem cells (NSCs) derived aggregates of neurospheres after 5–7 days of in vitro culture in NuroCult NS-A medium. The cells were maintained at 37 °C and 5%CO2 culture conditions. Immunocytochemistry of NSCs for CD133 (b-d) and Nestin expression (e-g) using specific antibodies for the respective antigen. Differentiation of NSCs to oligodendrocyte and astrocyte was assessed by immunostaining for CNPase (Oligodendrocytes specific marker; h-j) and GFAP (astrocytes specific marker; k-m) expression using specific antibodies for the respective antigen. The cells were subjected to tri-lineage differentiation assay in vitro. (n-p) The neural differentiation of NSCs was confirmed by MAP-2 antibody staining

NSCs sphere formation and proliferation

Treatment with NaB clearly changed the culture characteristics of NSCs in comparison with the untreated control NSCs that were maintained under similar culture conditions. The most obvious difference between the two groups of cells was that NaB treatment markedly reduced their ability to form neurospheres despite significantly enhanced rate of cluster formation (p < 0.05 vs control) (Fig. 2a-b). A continuous treatment for 10 days promoted neuronal differentiation of the clusters which had elongated morphology with distinct cell body, dendrite and axon (Fig. 2c). Neural differentiation was confirmed by MAP-2 expression using fluorescence immunocytochemistry (Fig. 3a-c) and flow cytometry (Fig. 3d-e). As compared to the control non-treated cells, 78.1% cells differentiated into neurons after 10 days treatment with NaB (Fig. 3d-e). The flow cytometry data showed that NaB treatment for HDAC inhibition significantly enhanced the neural differentiation.

Fig. 2

Sodium butyrate (NaB) treatment of neural stem cells (NSCs). a Treatment of NSCs with NaB decreased the rate of neurosphere formation whereas the rate of cluster formation was significantly increased as compared to the non-treated control cells (P < 0.05). b Phase contrast image of neural clusters after treatment with NaB. c Phase contrast image of the derivative neurons after 10-day treatment with NaB

Fig. 3

Sodium butyrate (NaB) enhances neural differentiation of neural stem cells (NSCs). a-c Immunocytochemistry of NSCs for neural differentiation using MAP (green fluorescence) as neuron specific marker using specific antibody. The nuclei were visualized using DAPI (blue fluorescence). d, e Flow cytometeric analysis of derivative neurons to ascertain the rate of neuronal differentiation which increased significantly subsequent to NaB. Up to 78.1% NSCs were differentiated after NaB treatment as compared to the non-treated (0.66%) controls

Cell viability

An interesting feature of our study was that NaB treatment preconditioned the cells towards subsequent exposure to H2O2. The viability of NaB treated cells was significantly higher as compared to the non-preconditioned cells upon subsequent exposure to H2O2. However, preconditioning with NaB in the presence of nicorandil significantly enhanced the cell viability further as compared to the control as well as NaB alone treated cells as assessed by MTT assay (p < 0.05; Fig. 4).

Fig. 4

Sodium butyrate (NaB) treatment preconditions NSCs. MTT assay showed that that viability of NaB treated NSCs increased significantly upon exposure to oxidative stress as compared to the non-treated control cells. The group of cells with combined treatment of NaB and Nicorandil showed the highest rate of cell viability after H2O2 exposure as compared to the other groups (p < 0.05 vs all other groups of cells)

Caspase-3 activity and annexin-V assays

Caspase-3 plays an important role in cell apoptosis and initiates the execution-phase of the apoptosis [17]. Hence, caspase-3 activity was measured to identify the apoptotic cells in different treatment cell groups upon exposure to H2O2 (Fig. 5a). The caspase-3 activity was significantly higher in the non-treated cell group upon exposure to H2O2 as compared to the NaB and combined (NaB + nicorandil) treatment groups whereas least activity of caspase-3 was observed in the combined (NaB + nicorandil) treatment group. Untreated cells without exposure to H2O2 were used as baseline control (Fig. 5a). These results were well supported by Annexin-V flow cytometry assay which showed that the percentage of Annexin-V positive cells was 19.3% in the untreated control cells upon exposure to oxidative stress as compared to 16.3% in NaB preconditioned cells and 10.6% in the combined (NaB and nicorandil) treatment group (p < 0.005 vs control; Fig. 5b-g). PI staining combined with flow cytometry showed that the more than 99% cell death was due to apoptosis (Fig. 5f-g).

Fig. 5

Preconditioning effect of combined treatment of NSCs with Sodium butyrate (NaB) and Nicorandil. Combined treatment with NaB and nicorandil significantly reduced NSCs apoptosis upon subsequent exposure to oxidative stress could diminish the apoptosis after stress oxidative exposure. a Caspase 3 activity was significantly higher in the untreated NSCs after exposure to oxidative stress whereas preconditioning with either NaB or nicorandil treatment alone significantly reduced caspase 3 activity. Lowest caspase 3 activity was observed in the cells which had combined pre-treatment with NaB and Nicorandil. b-e Similarly, Annexin V assay showed lowest apoptosis in the combined (NaB and nicorandil) treatment group. Untreated cells without exposure to oxidative stress were used as baseline control. Propidium iodide staining showed that the more than 99% cell death was because of the apoptosis and not due to necrosis (f-g)

Cell proliferation assay by BrdU labeling

To assess the proliferation of NSCs after NaB treatment, the cells were labeled with BrdU. The number of the NaB treated cells positive for (Brdu+/total cells) was (1.06 ± 0.04) as compared to the untreated control group (1.18 ± 0.10; p < 0.05) (Fig. 6).

Fig. 6

Cell proliferation assay. The cell proliferation assay using BrdU labeling showed that treatment of sodium butyrate (NaB) attenuated the rate of neural cell proliferation. There was significant difference between the NaB treated and untreated control groups (p < 0.05). (a) Quantitative assessments of Brdu positive cells. (b-h) Proliferating cells in different groups

Discussion

The main finding of our study is that NSCs treated with NaB successfully produce preconditioned neurons while subsequent treatment with nicorandil accentuates the preconditioning effect of NaB and enhances their survival upon subsequent exposure to H2O2.

The rate of neuronal differentiation of NSCs without teratogenicity and the ability of the differentiated cells to survive in the ischemic environment post-engraftment are two of the major challenges in stem cell-based therapy [18, 19]. Spontaneous malignant transformation of NSCs after long-term culture has been attributed to their extensive proliferation potential [20]. Molecular studies have shown constitutively higher NFkB activity, enhanced VEGF expression and adoption of tumorgenic phenotype in NSCs under growth factor-free culture conditions (in the absence of EGF and bFGF) [21]. Neutralization of VEGF significantly reduces the proliferation potential of NSCs in the growth factor-free culture and promotes their differentiation [22]. Various strategies have been adopted to promote their rate of neuronal differentiation. For example, alleviation of hypoxia in the developing cortex through angiogenesis promotes neurogenic differentiation of NSCs [23]. Similarly, exploiting the critical role of cell cycle regulators to prepare the cells for differentiation via cell cycle exit, double knock-down of cyclin dependent kinase (cdk)2 and cdk4 significantly enhances neuronal differentiation of neuronal precursors both in vivo and in culture conditions [24]. Supported by the loss-of-function studies, both cell proliferation and survival are significantly affected by the class-I HDACs [25, 26]. HDACi treatment stops the proliferation and sphere-forming potential of NSCs and supports their neural differentiation [27-29]. These data vividly support our findings that treatment with NaB enhances neural differentiation of NSCs. We observed that NaB effectively suppressed the rate of NSCs proliferation as was evident from increased cell cluster formation and their reduced sphere-forming ability. At molecular levels, previous studies have shown that NaB inhibits deacetylation of the lysine and arginine residues on the N-terminus of histones with concomitant increase in p21 which is responsible for anti-proliferative effects of the HDACi [30-33]. Their exit from cell cycle is accompanied by change of fate as a result of which NSCs become committed to tri-neural lineage fate, with neural differentiation as the dominant prospect [8, 34]. A recent study has shown that pro-neural genes Ngn2 and NeuroD1 are elevated during HDACi treatment with a consequent increase in neural differentiation [35]. Our results are in agreement with the published reports and show that NaB induce significantly higher neural differentiation of NSCs in comparison with the non-treated control NSCs as determined by MAP-2 antigen expression.

Besides exit from cell cycle and neural differentiation, cytoprotection afforded by NaB was the cardinal feature of our study. The NaB treated cells were more resistant to H2O2 induced apoptosis than the untreated control cells (p < 0.05 vs untreated control cells) as determined by MTT and caspase-3 assays. Neuroprotective effects of NaB have also been reported in the retinal glial cells cultured under serum-free conditions at par with erythropoietin [36]. Mechanistic studies have shown that cytoprotection with NaB was mediated via activation of PI3K/Akt signaling [37]. Treatment with NaB significantly reduced the number of apoptotic neurons during cerebral ischemia-reperfusion injury in experimental mouse model. The authors have reported significantly elevated Bcl2 and phosphorylated Akt, and reduced caspase-3 and Bax expression as compared to the non-treated experimental animals. Enhanced resistance to oxidative stress has also been reported in rat hippocampus via elevated levels of thiorexidine binding protein-2 (TBP-2) after NaB treatment which was attributed to antioxidant effects of TBP-2 [38]. We observed that combined treatment of NSCs with NaB and nicorandil was more cytoprotective as compared to treatment of the cells with either of the two molecules alone. Nicorandil is a small molecule capable of stimulating APE1/Ref1 activity in the cells which is responsible for cell reaction to DNA damage and oxidative stress [39]. The cytoprotective effects of APE1/Ref1 have been attributed to modulation of transcription factors including activator protein-1 (AP-1), NF-ĸB, p53, cAMP response element binding protein (CREB), and hypoxia-inducible factor-1α (HIF-1α) [14, 40, 41]. Based on these data, we propose that nicorandil treatment activated APE1 in the neurons after treatment with HDACi. Further studies are warranted to fully understand the underlying molecular mechanism and efficacy of the combined cytoprotective effects of NaB and nicorandil.

Notwithstanding the interesting data, the study has some limitations. Firstly, we focused only on the apoptosis markers for evaluation of the preconditioning effects of NaB and nicorandil. Although H2O2 has been widely accepted as an inducer of apoptosis in various cell-based studies, it may induce cell death by multiple mechanisms [42-44]. Study of the oxidative stress markers would have enhanced the significance of the data. Secondly, future studies will be required to understand the mechanism of cytoprotection afforded by the combined treatment with NaB and nicorandil using HDAC-mutant cells, loss-of-function and gain-of-function studies to understand the role of p21 in proliferation of the preconditioned cells besides their cell cycle marker expression profile.

Conclusion

In conclusion, combined treatment with NaB and nicorandil is effective to enhance neural commitment of NSCs and cytoprotection of the derivative neural cells.